Eli Lilly Stock Soars as Mounjaro, Zepbound Power Earnings Beat, Guidance Boost
Eli Lilly shares jumped Thursday after its second-quarter results soared past estimates and led the drugmaker to lift its full-year sales and profit guidance.
( 21
min )